Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT07256457
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥18 years
2. Histologically or cytologically confirmed stage IA NSCLC (T1N0M0, tumor ≤3 cm)
3. Scheduled for surgical treatment (segmentectomy or lobectomy or robotic/navigation-guided bronchoscopic ablation)
4. Ability to complete postoperative visits for up to 2 years
5. Provided informed consent
Exclusion Criteria:
1. Presence of lymph node involvement (N1 or higher) or distant metastases (M1)
2. Concomitant primary malignancies that could confound outcome analysis
3. Insufficient or missing key data points (e.g., tumor size, treatment type, survival status)
4. Duplicate or overlapping records from different data sources
5. Contraindications to anesthesia or sedation for bronchoscopy or surgery
6. Inability or unwillingness to perform the PF tests
7. Pregnant or breastfeeding women (for prospective phase)
8. Inability or unwillingness to comply with study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07256457
Study Brief:
Protocol Section:
NCT07256457